Retinitis pigmentosa stem cell study tops ARVO news

The annual Association for Research in Vision and Ophthalmology meeting was held in Vancouver, British Columbia, from April 28 to May 2.
Here are the top five stories and videos from’s coverage of the meeting:
Phase 2a study shows improved vision with stem cell therapy for retinitis pigmentosa
Human retinal progenitor cell therapy from ReNeuron Group is showing positive preliminary results in the company’s ongoing phase 1/2a clinical trial involving patients with retinitis pigmentosa. Read more.
Most weight loss strategies associated with increased risk of

Full Story →